Non-Clinical Development Intern
Olema Oncology
About this role
A Non-Clinical Development Intern at Olema Oncology gains hands-on experience in drug development, supporting nonclinical studies, and working across disciplines to advance oncology therapies.
Skills
Qualifications
About Olema Oncology
olema.comOlema Oncology is a cancer medicines company focused on innovating therapies for breast cancer and other endocrine-driven tumors. The company is rapidly advancing a pipeline of drug candidates designed to target the biology of endocrine-driven disease. Olema’s work centers on translating cutting‑edge science into treatments that meaningfully impact patients, progressing programs toward clinical evaluation.
Recent company news
SahmOlema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1 week ago
Yahoo FinanceOlema Oncology Announces Departure of Chief Operating and Financial Officer
1 month ago
Stock TitanBreast cancer-focused Olema sees financial officer depart, CEO steps in
1 month ago
GlobeNewswireOlema Oncology to Present at the TD Cowen 46th Annual Health Care Conference
3 weeks ago
Yahoo FinanceOlema Oncology Announces Pricing of $190.0 Million Public Offering of Common Stock
Nov 19, 2025
About Olema Oncology
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Olema Oncology.
Salary
$42k
per year
More jobs at Olema Oncology
Similar Jobs
Intern, Biostatistics
Revolution Medicines
Associate Director, Statistics
AbbVie
Vice President, Clinical Development
Kura Oncology
Senior Scientist, DMPK
Ellison Medical Institute of Los Angeles
Intern – Medical Technologist [ Clinical Chemistry ]
Labcorp
Manager, Clinical Scientist, Oncology
Regeneron Pharmaceuticals